257 related articles for article (PubMed ID: 29188480)
1. A function-blocking CD47 antibody modulates extracellular vesicle-mediated intercellular signaling between breast carcinoma cells and endothelial cells.
Kaur S; Elkahloun AG; Singh SP; Arakelyan A; Roberts DD
J Cell Commun Signal; 2018 Mar; 12(1):157-170. PubMed ID: 29188480
[TBL] [Abstract][Full Text] [Related]
2. A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer.
Kaur S; Elkahloun AG; Singh SP; Chen QR; Meerzaman DM; Song T; Manu N; Wu W; Mannan P; Garfield SH; Roberts DD
Oncotarget; 2016 Mar; 7(9):10133-52. PubMed ID: 26840086
[TBL] [Abstract][Full Text] [Related]
3. Effects of a humanized CD47 antibody and recombinant SIRPα proteins on triple negative breast carcinoma stem cells.
Kaur S; Reginauld B; Razjooyan S; Phi T; Singh SP; Meyer TJ; Cam MC; Roberts DD
Front Cell Dev Biol; 2024; 12():1356421. PubMed ID: 38495618
[TBL] [Abstract][Full Text] [Related]
4. CD47-dependent immunomodulatory and angiogenic activities of extracellular vesicles produced by T cells.
Kaur S; Singh SP; Elkahloun AG; Wu W; Abu-Asab MS; Roberts DD
Matrix Biol; 2014 Jul; 37():49-59. PubMed ID: 24887393
[TBL] [Abstract][Full Text] [Related]
5. PML-RARa modulates the vascular signature of extracellular vesicles released by acute promyelocytic leukemia cells.
Fang Y; Garnier D; Lee TH; D'Asti E; Montermini L; Meehan B; Rak J
Angiogenesis; 2016 Jan; 19(1):25-38. PubMed ID: 26374632
[TBL] [Abstract][Full Text] [Related]
6. CD63
Kaur S; Elkahloun AG; Petersen JD; Arakelyan A; Livak F; Singh SP; Margolis L; Zimmerberg J; Roberts DD
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829933
[TBL] [Abstract][Full Text] [Related]
7. IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.
Lombardo G; Gili M; Grange C; Cavallari C; Dentelli P; Togliatto G; Taverna D; Camussi G; Brizzi MF
Oncogene; 2018 Mar; 37(9):1175-1191. PubMed ID: 29238040
[TBL] [Abstract][Full Text] [Related]
8. CD47 is a direct target of SNAI1 and ZEB1 and its blockade activates the phagocytosis of breast cancer cells undergoing EMT.
Noman MZ; Van Moer K; Marani V; Gemmill RM; Tranchevent LC; Azuaje F; Muller A; Chouaib S; Thiery JP; Berchem G; Janji B
Oncoimmunology; 2018; 7(4):e1345415. PubMed ID: 29632713
[TBL] [Abstract][Full Text] [Related]
9. Breast-cancer extracellular vesicles induce platelet activation and aggregation by tissue factor-independent and -dependent mechanisms.
Gomes FG; Sandim V; Almeida VH; Rondon AMR; Succar BB; Hottz ED; Leal AC; Verçoza BRF; Rodrigues JCF; Bozza PT; Zingali RB; Monteiro RQ
Thromb Res; 2017 Nov; 159():24-32. PubMed ID: 28950217
[TBL] [Abstract][Full Text] [Related]
10. The emerging role of breast cancer derived extracellular vesicles-mediated intercellular communication in ovarian cancer progression and metastasis.
Yıldırım MR; Kırbaş OK; Abdik H; Şahin F; Avşar Abdik E
Med Oncol; 2023 Dec; 41(1):30. PubMed ID: 38148465
[TBL] [Abstract][Full Text] [Related]
11. CD47 deficiency in tumor stroma promotes tumor progression by enhancing angiogenesis.
Gao L; Chen K; Gao Q; Wang X; Sun J; Yang YG
Oncotarget; 2017 Apr; 8(14):22406-22413. PubMed ID: 27283989
[TBL] [Abstract][Full Text] [Related]
12. Effects of Low- and High-Dose Chemotherapy Agents on Thrombogenic Properties of Extracellular Vesicles Derived from Breast Cancer Cell Lines.
Aharon A; Sabbah AR; Issman L; Berkovich H; Copty R; Talmon Y; Brenner B
Thromb Haemost; 2018 Mar; 118(3):480-489. PubMed ID: 29490409
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Vesicles From Osteotropic Breast Cancer Cells Affect Bone Resident Cells.
Loftus A; Cappariello A; George C; Ucci A; Shefferd K; Green A; Paone R; Ponzetti M; Delle Monache S; Muraca M; Teti A; Rucci N
J Bone Miner Res; 2020 Feb; 35(2):396-412. PubMed ID: 31610048
[TBL] [Abstract][Full Text] [Related]
14. Effects of protein tyrosine kinase inhibitors on cytokine-induced adhesion molecule expression by human umbilical vein endothelial cells.
May MJ; Wheeler-Jones CP; Pearson JD
Br J Pharmacol; 1996 Aug; 118(7):1761-71. PubMed ID: 8842442
[TBL] [Abstract][Full Text] [Related]
15. Linoleic acid induces secretion of extracellular vesicles from MDA-MB-231 breast cancer cells that mediate cellular processes involved with angiogenesis in HUVECs.
Garcia-Hernandez A; Leal-Orta E; Ramirez-Ricardo J; Cortes-Reynosa P; Thompson-Bonilla R; Salazar EP
Prostaglandins Other Lipid Mediat; 2021 Apr; 153():106519. PubMed ID: 33238201
[TBL] [Abstract][Full Text] [Related]
16. CD47 interactions with exportin-1 limit the targeting of m
Kaur S; Saldana AC; Elkahloun AG; Petersen JD; Arakelyan A; Singh SP; Jenkins LM; Kuo B; Reginauld B; Jordan DG; Tran AD; Wu W; Zimmerberg J; Margolis L; Roberts DD
J Cell Commun Signal; 2022 Sep; 16(3):397-419. PubMed ID: 34841476
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicles from MDA-MB-231 breast cancer cells stimulated with linoleic acid promote an EMT-like process in MCF10A cells.
Galindo-Hernandez O; Serna-Marquez N; Castillo-Sanchez R; Salazar EP
Prostaglandins Leukot Essent Fatty Acids; 2014 Dec; 91(6):299-310. PubMed ID: 25301203
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer.
Tsai YF; Tseng LM; Hsu CY; Yang MH; Chiu JH; Shyr YM
PLoS One; 2017; 12(6):e0178173. PubMed ID: 28604807
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles secreted by triple-negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungs.
González-Callejo P; Gener P; Díaz-Riascos ZV; Conti S; Cámara-Sánchez P; Riera R; Mancilla S; García-Gabilondo M; Peg V; Arango D; Rosell A; Labernadie A; Trepat X; Albertazzi L; Schwartz S; Seras-Franzoso J; Abasolo I
Int J Cancer; 2023 May; 152(10):2153-2165. PubMed ID: 36705298
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1-containing extracellular vesicles transport adhesion proteins and promote malignancy in breast cancer cell lines.
Campos A; Salomon C; Bustos R; Díaz J; Martínez S; Silva V; Reyes C; Díaz-Valdivia N; Varas-Godoy M; Lobos-González L; Quest AF
Nanomedicine (Lond); 2018 Oct; 13(20):2597-2609. PubMed ID: 30338706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
